Cargando…
Regenerative Potential of the Product “CardioCell” Derived from the Wharton’s Jelly Mesenchymal Stem Cells for Treating Hindlimb Ischemia
In recent years, mesenchymal stem cells (MSCs) have emerged as a promising therapeutic modality in regenerative medicine. They hold great promise for treating civilization-wide diseases, including cardiovascular diseases, such as acute myocardial infarction and critical limb ischemia. MSCs isolated...
Autores principales: | Musiał-Wysocka, Aleksandra, Kot, Marta, Sułkowski, Maciej, Majka, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770009/ https://www.ncbi.nlm.nih.gov/pubmed/31540534 http://dx.doi.org/10.3390/ijms20184632 |
Ejemplares similares
-
Molecular and Functional Verification of Wharton’s Jelly Mesenchymal Stem Cells (WJ-MSCs) Pluripotency
por: Musiał-Wysocka, Aleksandra, et al.
Publicado: (2019) -
Nuclear magnetic resonance footprint of Wharton Jelly mesenchymal stem cells death mechanisms and distinctive in‐cell biophysical properties in vitro
por: Krzyżak, Artur T., et al.
Publicado: (2022) -
AFM-based Analysis of Wharton’s Jelly Mesenchymal Stem Cells
por: Szydlak, Renata, et al.
Publicado: (2019) -
The Pros and Cons of Mesenchymal Stem Cell-Based Therapies
por: Musiał-Wysocka, Aleksandra, et al.
Publicado: (2019) -
Application of the CardioCel bovine pericardial patch – a preliminary report
por: Sobieraj, Michał, et al.
Publicado: (2016)